Thermo Fisher Scientific Inc (TMO) insider trading
Every open-market stock purchase and sale by Thermo Fisher Scientific Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Healthcare.
Insider activity at a glance
- Marc N Casper (CEO) and 4 others sold $61.2M in the last 90 days.
- Last insider buy: Nelson Chai (Director), $2.1K, 22 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $157M (26 sales). Last close $618.43 on Sep 3, 2026.
Recent TMO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 26, 2026 | Scott M Sperling (Director) | Bought (not open market) | — |
| Sep 26, 2026 | Dion J Weisler (Director) | Bought (not open market) | — |
| Sep 26, 2026 | Jennifer M Johnson (Director) | Bought (not open market) | — |
| Sep 26, 2026 | R. Alexandra Keith (Director) | Bought (not open market) | — |
| Sep 26, 2026 | Karen S Lynch (Director) | Bought (not open market) | — |
| Aug 31, 2026 | Gianluca Pettiti (COO) | Sold | $2.3M |
| Aug 31, 2026 | Gianluca Pettiti (COO) | Sold | $246K |
| Aug 31, 2026 | Gianluca Pettiti (COO) | Bought (not open market) | — |
| Aug 28, 2026 | Marc N Casper (CEO) | Sold (not open market) | $451K |
| Aug 28, 2026 | Marc N Casper (CEO) | Sold (not open market) | $331K |
| Aug 28, 2026 | Gianluca Pettiti (COO) | Sold (not open market) | $189K |
| Aug 28, 2026 | Gianluca Pettiti (COO) | Sold (not open market) | $168K |
| Aug 28, 2026 | Gianluca Pettiti (COO) | Sold (not open market) | $155K |
| Aug 28, 2026 | Michael D Shafer (President) | Sold (not open market) | $141K |
| Aug 28, 2026 | Gianluca Pettiti (COO) | Sold (not open market) | $132K |
| Aug 28, 2026 | Michael D Shafer (President) | Sold (not open market) | $131K |
| Aug 28, 2026 | Michael D Shafer (President) | Sold (not open market) | $118K |
| Aug 28, 2026 | Michael D Shafer (President) | Sold (not open market) | $101K |
| Aug 28, 2026 | Lisa P. Britt (C-suite exec) | Sold (not open market) | $72.2K |
| Aug 28, 2026 | James Meyer (CFO) | Sold (not open market) | $70.7K |
| Aug 28, 2026 | Lisa P. Britt (C-suite exec) | Sold (not open market) | $65.6K |
| Aug 28, 2026 | Lisa P. Britt (C-suite exec) | Sold (not open market) | $54.1K |
| Aug 28, 2026 | Lisa P. Britt (C-suite exec) | Sold (not open market) | $52.9K |
| Aug 28, 2026 | James Meyer (CFO) | Sold (not open market) | $34.3K |
| Aug 28, 2026 | Thomas B Shropshire Jr. (VP) | Sold (not open market) | $30.5K |
Who's trading TMO
- Jennifer M Johnson, Director: other filings, last Sep 26, 2026
- Scott M Sperling, Director: other filings, last Sep 26, 2026
- Karen S Lynch, Director: other filings, last Sep 26, 2026
- R. Alexandra Keith, Director: other filings, last Sep 26, 2026
- Dion J Weisler, Director: other filings, last Sep 26, 2026
- Gianluca Pettiti, President: sold $5.1M (8 sales), last Aug 31, 2026
- Michael D Shafer, President: sold $22.5M (5 sales), last Aug 28, 2026
- Joseph R. Holmes, C-suite exec: sold $246K (1 sale), last Aug 28, 2026
- Thomas B Shropshire Jr., VP: other filings, last Aug 28, 2026
- Lisa P. Britt, C-suite exec: sold $16.9M (5 sales), last Aug 28, 2026
- Marc N Casper, CEO: sold $53.3M (127 sales), last Aug 28, 2026
- James Meyer, CFO: other filings, last Aug 28, 2026
- Nelson Chai, Director: other filings, last May 20, 2026
- C Martin Harris, Director: other filings, last May 20, 2026
- Tyler Jacks, Director: other filings, last May 20, 2026
Get free alerts when an insider at Thermo Fisher Scientific Inc files a new trade →